IXI Platform & Collaborations Update

Summary by AI BETAClose X

IXICO released an updated IXI™ platform that improves clinical-trial operational efficiency, image quality control, user experience and scalability for external commercial use, and announced collaborations integrating Neuropacs’ FDA De Novo-authorised neuropacs™ AIDP Parkinson’s algorithm and ZRO Imaging’s advanced PET quantitative tools; the company states these moves create opportunities for recurring revenue via technology licensing and partnerships, expand its addressable market, strengthen iCRO services and were independently validated by winning Technology Innovation of the Year at the Citeline Biotech Awards 2026.

Disclaimer*

Companies

Ixico (IXI)
UK 100

Latest directors dealings